HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS Psychiatric Bulletin Advances in Psychiatric Treatment All RCPsych Journals		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Thompson, J. M. Articles by Young, A. H. Search for Related Content PubMed PubMed Citation Articles by Thompson, J. M. Articles by Young, A. H.

Neurocognitive impairment in euthymic patients with bipolar affective disorder

Stanley Research Centre, School of Neurology, Neurobiology and Psychiatry, University of Newcastle upon Tyne, UK

Correspondence: Professor A. H. Young, Stanley Research Centre, School of Neurology, Neurobiology and Psychiatry (Psychiatry), University of Newcastle upon Tyne, Leazes Wing, Royal Victoria Infirmary, Newcastle upon Tyne NE1 4LP, UK. Tel: +44 (0)191 2824473; fax +44 (0)191 2275108; e-mail: a.h.young{at}ncl.ac.uk

Declaration of interest None.

Funding detailed in Acknowledgements.

Background Persistent impairments in neurocognitive function have been described in patients with bipolar disorder whose disease is in remission. However, methodological issues such as the effect of residual mood symptoms and hypercortisolaemia may confound such studies.

Aims To assess neurocognitive functioning in prospectively verified euthymic patients with bipolar disorder.

Method Sixty-three patients with bipolar disorder and a matched control group completed a comprehensive neurocognitive test battery. Euthymia was confirmed in the patient group by prospective clinical ratings over 1 month prior to testing. Saliva samples were collected to profile basal cortisol secretion.

Results Patients were significantly impaired across a broad range of cognitive domains. Across the domains tested, clinically significant impairment was observed in 3% to 42% of patients. Deficits were not causally associated with residual mood symptoms or hypercortisolaemia.

Conclusions Neurocognitive impairment persists in patients whose bipolar disorder is in remission. This may represent a trait abnormality and be a marker of underlying neurobiological dysfunction.

This article has been cited by other articles:

				A. Pfennig, E. Littmann, and M. Bauer Neurocognitive Impairment and Dementia in Mood Disorders J Neuropsychiatry Clin Neurosci, November 1, 2007; 19(4): 373 - 382. [Abstract] [Full Text] [PDF]

				P. V. Nunes, O. V. Forlenza, and W. F. Gattaz Lithium and risk for Alzheimer's disease in elderly patients with bipolar disorder The British Journal of Psychiatry, April 1, 2007; 190(4): 359 - 360. [Abstract] [Full Text] [PDF]

				U. S. KOLUR, Y.C.J. REDDY, J.P. JOHN, T. KANDAVEL, and S. JAIN Sustained attention and executive functions in euthymic young people with bipolar disorder The British Journal of Psychiatry, November 1, 2006; 189(5): 453 - 458. [Abstract] [Full Text] [PDF]

				R. Bharadwaj Cognitive impairment in euthymic patients with bipolar disorder The British Journal of Psychiatry, November 1, 2006; 189(5): 468 - 469. [Full Text] [PDF]

				C. Torrent, A. Martinez-Aran, C. Daban, J. Sanchez-Moreno, M. Comes, J. M. Goikolea, M. Salamero, and E. Vieta Cognitive impairment in bipolar II disorder The British Journal of Psychiatry, September 1, 2006; 189(3): 254 - 259. [Abstract] [Full Text] [PDF]

				P. Tyrer From the Editor's desk The British Journal of Psychiatry, September 1, 2006; 189(3): 294 - 294. [Full Text] [PDF]

				M. M. Al-Uzri, M. A. Reveley, L. Owen, J. Bruce, S. Frost, D. Mackintosh, and P. M. Moran Measuring memory impairment in community-based patients with schizophrenia: Case-control study The British Journal of Psychiatry, August 1, 2006; 189(2): 132 - 136. [Abstract] [Full Text] [PDF]

				I. N. Ferrier, L. J. Ferrie, and K. A. Macritchie Old drug, new data: REVISITING... LITHIUM THERAPY Advan. Psychiatr. Treat., July 1, 2006; 12(4): 256 - 264. [Abstract] [Full Text] [PDF]

				U. GOSWAMI, A. SHARMA, U. KHASTIGIR, I. N. FERRIER, A. H. YOUNG, P. GALLAGHER, J. M. THOMPSON, and P.B. MOORE Neuropsychological dysfunction, soft neurological signs and social disability in euthymic patients with bipolar disorder The British Journal of Psychiatry, April 1, 2006; 188(4): 366 - 373. [Abstract] [Full Text] [PDF]

				R. H. McAllister-Williams Relapse prevention in bipolar disorder: a critical review of current guidelines. J Psychopharmacol, March 1, 2006; 20(2 Suppl): 12 - 16. [Abstract] [PDF]

				A. H. Young and J. I. Newham Lithium in maintenance therapy for bipolar disorder. J Psychopharmacol, March 1, 2006; 20(2 Suppl): 17 - 22. [Abstract] [PDF]

				M. N. Pavuluri, L. S. Schenkel, S. Aryal, E. M. Harral, S. K. Hill, E. S. Herbener, and J. A. Sweeney Neurocognitive Function in Unmedicated Manic and Medicated Euthymic Pediatric Bipolar Patients Am J Psychiatry, February 1, 2006; 163(2): 286 - 293. [Abstract] [Full Text] [PDF]

				Drug treatments for bipolar disorder: 1 - Acute manic or depressive DTB, April 1, 2005; 43(4): 28 - 32. [Abstract] [Full Text] [PDF]

				Cognitive Impairment in Euthymic Bipolar Patients Journal Watch Psychiatry, February 24, 2005; 2005(224): 2 - 2. [Full Text]